Surgery Partners, Inc. Ratios

Ratios Dec2013 Dec2014 Dec2015 Dec2016 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 40.32%36.97%30.27%28.31%72.32%72.27%71.06%71.40%72.05%72.84%73.90%
EBT Margin 8.89%-2.80%-7.93%8.05%-3.91%2.98%-1.01%3.65%4.34%4.92%4.72%
EBIT Margin 20.46%12.60%15.08%17.15%4.39%12.88%9.84%13.58%13.59%11.96%11.20%
EBITDA Margin 20.46%12.60%17.74%19.77%7.92%16.81%14.70%17.83%18.01%16.07%15.85%
Operating Margin 20.46%12.60%15.08%17.15%4.39%12.88%9.84%13.58%13.59%11.96%11.20%
Net Margin 6.23%-6.71%0.15%0.83%-13.44%-6.03%-8.37%-3.65%-2.15%-0.43%0.40%
FCF Margin 15.79%3.52%5.32%7.52%5.92%3.05%10.97%1.33%3.08%7.47%6.73%
Efficiency
Inventory Average 24.64M27.18M36.09M44.85M51.35M58.75M66.25M73.30M81.80M
Assets Average 1,981.62M2,204.70M3,490.63M4,847.60M5,216.05M5,765.40M6,399.85M6,779.40M7,383.35M
Equity Average -168.30M-321.52M1.94M711.79M1,041.15M932.75M1,425.85M2,455.25M2,987.70M3,115.45M
Invested Capital -14.38M523.95M540.50M1,256.67M3,427.04M2,417.50M2,421.50M4,927.90M5,575.00M5,838.30M6,601.00M
Asset Utilization Ratio 0.480.520.510.380.360.390.400.400.42
Leverage & Solvency
Debt to Equity -4.22-3.914.442.122.623.241.490.890.911.05
Debt Ratio 0.730.600.630.500.510.530.480.390.400.43
Equity Ratio -0.17-0.150.140.230.200.160.320.440.440.41
Dividends & Payouts
FCF Payout Ratio 0.562.481.370.761.042.170.544.441.880.710.81
Valuation
Enterprise Value -13.03M117.67M1,112.24M1,027.41M620.95M543.26M1,453.75M4,343.25M2,565.12M4,897.92M3,828.19M
Market Capitalization 986.74M916.58M478.65M314.96M1,464.85M4,402.95M2,506.02M4,046.52M2,690.99M
Return Ratios
Return on Sales 0.06%-0.07%0.08%0.07%-0.05%0.02%0.00%0.03%0.03%0.05%0.00%
Return on Capital Employed 0.08%0.10%0.02%0.05%0.04%0.06%0.06%0.05%0.05%
Return on Invested Capital 0.20%0.07%0.07%0.05%0.00%
Return on Assets 0.04%0.04%-0.03%0.01%0.00%0.01%0.01%0.02%0.00%
Return on Equity 0.16%-0.23%43.97%-0.13%0.04%0.00%0.05%0.04%0.05%0.00%